IP Tech Blog

MAY 19, 2023

billion by 2025, at a compound annual growth rate of 32%. Influencer marketing offers brands a unique opportunity to target and connect with online communities, using a personalized approach. Parties : Consider the parties involved in the arrangement and ensure that the appropriate parties are reflected in any formal contracts.

Marketing 57

Marketing Marketing Branding Brands 57

LexBlog IP

MAY 19, 2023

billion by 2025, at a compound annual growth rate of 32%. Influencer marketing offers brands a unique opportunity to target and connect with online communities, using a personalized approach. Parties : Consider the parties involved in the arrangement and ensure that the appropriate parties are reflected in any formal contracts.

Marketing 52

Marketing Marketing Contracts Branding 52

LexBlog IP

JULY 13, 2022

On Thursday, July 7, 2022, California Governor Gavin Newsom announced that the most recent state budget, signed last week, includes a $100 million allotment for California to “contract to make [its] own insulin at a cheaper price, close to at cost.” ” The budget also includes “$700,000 ($2.8 ” The post CA Gov.

Contracts 52

Contracts Branding Brands Branding 52

Michael Geist

MARCH 21, 2023

Supporters note that document demands are not unprecedented – there have been requests with respect to McKinsey and We Charity – but those involved concerns about completed contracts or programs, not internal analysis of legislation. This targets the companies’ response to legislation without evidence of wrongdoing.

Government 96

Government Journalism Contracts Branding 96

Fish & Richardson Trademark & Copyright Thoughts

DECEMBER 2, 2020

billion by 2025. [ii] Trademark protection is available for cannabis companies (canna-brands) through a combination of federal, state, and common law sources. This is primarily due to the centuries-old Illegality Doctrine, which holds that a court may not enforce claims or contracts that are based in illegal acts.

IP 52

IP Registration Trademark Branding 52

Fish & Richardson Trademark & Copyright Thoughts

FEBRUARY 4, 2021

BI argues that FDA’s current interpretation “encourages, or at least permits, brand sponsors to use minor concentration changes as an anti-competitive tactic.” license and the ability to bring a biosimilar to market in March 2025. BI points to Humira ® (adalimumab) as an example. The first case, brought by Pfizer (No. 17-cv-04180, E.D.

Litigation 52

Litigation Settlement Marketing Marketing 52